Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for anesthetic induction in cardiac surgery
KCT0006931Phase 4Recruiting
- Sponsor
- Hana Pharm
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in cardiac disease, sponsored by Hana Pharm. Started Apr 2022; status: recruiting.
02
Drugs
remimazolam
03
Conditions
cardiac disease
Beyond the preview
Go deeper on KCT0006931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006931.